Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2019 Sep 9;158(6):1680–1692.e2. doi: 10.1016/j.jtcvs.2019.08.033

Table 1.

Background characteristics of propensity score-matched patients with cN3 non-small cell lung cancer grouped by treatment

Chemoradiation (n=935) (%) Surgery (n=935) (%) Std Mean Difference p value
Age (years, median) 67(59–74) 67(59–74) 0.01 0.98
Sex (female) 405(43) 402(43) 0.07 0.93
Race 0.86
White 818(88) 811(87)
Black 95(10) 99(11) 0.01
Other 22(2) 25(3) 0.02
Year of diagnosis, median (inter-quartile range) 2010(2007–2013) 2010(2008–2012) −0.007 0.80
CDCC Score 0.75
0 526(56) 519(56)
1 274(29) 288(31) 0.03
2+ 135(14) 128(14) −0.02
Insurance status 0.65
Private 339(36) 331(35)
Government 562(60) 576(62) 0.03
None 34(4) 28(3) −0.04
Facility location 0.62
Metro 701(75) 711(76)
Urban 184(20) 169(18) −0.04
Rural 50(5) 55(6) 0.02
Academic center 336(36) 344(37) 0.02 0.74
Tumor size, median (mm) 32(22–44) 30(20–45) −0.05 0.11
Histology 0.87
Adenocarcinoma 446(48) 449(48)
Squamous cell carcinoma 353(38) 358(38) 0.01
Other 136(15) 128(14) −0.02
Perioperative chemotherapy 549(59) N/A N/A